Literature DB >> 10709110

The ubiquitin-activating enzyme E1-like protein in lung cancer cell lines.

P M McLaughlin1, W Helfrich, K Kok, M Mulder, S W Hu, M G Brinker, M H Ruiters, L F de Leij, C H Buys.   

Abstract

The UBE1L gene isolated from the chromosome 3p21 region has an extremely reduced level of mRNA in lung cancer. Sequence analysis showed a 45% homology to the human ubiquitin-activating enzyme E1 at the amino acid level. To further characterize the protein product, we generated UBE1L protein-specific antibodies. Immunoblot analysis revealed a full-length gene product of approximately 112 kDa. Assessment of the level and distribution pattern of the UBE1L protein in normal and tumor tissue using the generated antibodies showed that the UBE1L protein was present in normal lung cells and non-lung cancer cell lines, but was undetectable in all 14 human lung cancer cell lines analyzed. This difference in expression of the UBE1L protein between normal lung tissue and lung tumor-derived cell lines suggests a possible involvement of an E1-like protein in the origin and/or progression of lung tumors. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10709110     DOI: 10.1002/(sici)1097-0215(20000315)85:6<871::aid-ijc22>3.0.co;2-o

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  Viral defense, carcinogenesis and ISG15: novel roles for an old ISG.

Authors:  Ian F Pitha-Rowe; Paula M Pitha
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-03       Impact factor: 7.638

2.  Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.

Authors:  Young Joo Jeon; Mi Gyeong Jo; Hee Min Yoo; Se-Hoon Hong; Jung-Mi Park; Seung Hyeun Ka; Kyu Hee Oh; Jae Hong Seol; Yong Keun Jung; Chin Ha Chung
Journal:  J Clin Invest       Date:  2012-06-18       Impact factor: 14.808

Review 3.  Interferon-stimulated gene 15 and the protein ISGylation system.

Authors:  Dongxian Zhang; Dong-Er Zhang
Journal:  J Interferon Cytokine Res       Date:  2010-12-29       Impact factor: 2.607

4.  UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia.

Authors:  Sutisak Kitareewan; Ian Pitha-Rowe; David Sekula; Christopher H Lowrey; Michael J Nemeth; Todd R Golub; Sarah J Freemantle; Ethan Dmitrovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

5.  Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation.

Authors:  Keun Il Kim; Nadia V Giannakopoulos; Herbert W Virgin; Dong-Er Zhang
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

6.  UBE1L causes lung cancer growth suppression by targeting cyclin D1.

Authors:  Qing Feng; David Sekula; Yongli Guo; Xi Liu; Candice C Black; Fabrizio Galimberti; Sumit J Shah; Lorenzo F Sempere; Vincent Memoli; Jesper B Andersen; Bret A Hassel; Konstantin Dragnev; Ethan Dmitrovsky
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

7.  The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction.

Authors:  Bianca Dauber; Gudrun Heins; Thorsten Wolff
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Role of E3 ubiquitin ligases in lung cancer.

Authors:  Barbara C Snoek; Leonie Ham de Wilt; Gerrit Jansen; Godefridus J Peters
Journal:  World J Clin Oncol       Date:  2013-08-10

9.  Transmembrane Protein pUL50 of Human Cytomegalovirus Inhibits ISGylation by Downregulating UBE1L.

Authors:  Myoung Kyu Lee; Ye Ji Kim; Young-Eui Kim; Tae-Hee Han; Jens Milbradt; Manfred Marschall; Jin-Hyun Ahn
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

10.  Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification.

Authors:  Jong Ho Park; Seung Wook Yang; Jung Mi Park; Seung Hyeun Ka; Ji-Hoon Kim; Young-Yun Kong; Young Joo Jeon; Jae Hong Seol; Chin Ha Chung
Journal:  Nat Commun       Date:  2016-08-22       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.